BioSpace News Archive

MAIA Biotechnology, Inc. (NYSE American: MAIA ) today announced preliminary survival data in the Part A safety lead-in of its ongoing phase 2 trial, THIO-101 evaluating THIO in patients with advanced Non-Small Cell Lung Cancer (NSCLC).

Twist Bioscience Corporation today announced a collaboration with Astellas Pharma Inc.

Paragonix Technologies, Inc. has presented new groundbreaking data on the clinical impact of using Paragonix SherpaPak Cardiac Transport System to preserve donor hearts from extended criteria donors.

Precision BioSciences to Present Preclinical In Vivo Gene Editing Research for its ARCUS HBV Program at Upcoming Global Hepatitis Summit 2023.

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”) today announced completion of the safety evaluation stage of the highest dose cohort of patients with acute myeloid leukemia (AML) who relapsed after or were refractory to available antileukemic therapies in its Phase 1 dose escalation clinical trial of GFH009.

Windtree Therapeutics, Inc. today announced the pricing of its underwritten public offering of 3,686,006 shares of common stock and warrants to purchase up to 3,686,006 shares of common stock (the “Offering”).

Koning Corporation, the leading developer and manufacturer of the innovative Koning Vera Breast CT, is proud to announce its participation in the upcoming Society of Breast Imaging Symposium to be held May 4-7 in Washington, DC.

Lexaria Bioscience Corp., a global innovator in drug delivery platforms announces that it has received notifications of four new patents either awarded or allowed.

Insmed Incorporated today announced that it will release its first quarter 2023 financial results on Thursday, May 4, 2023.

NICO Corporation, a pioneer and leader in minimally invasive neurosurgery, today announced results from the completed ENRICH (Early MiNimally-invasive Removal of ICH) trial will be presented at the annual American Association of Neurological Surgeons (AANS) meeting in Los Angeles from April 21-24.